Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population

Molecular and Cellular Biochemistry

Volumn 350, Issue 1-2, 2011, Pages 119-125

  Al Harbi, Einas M ^a   Farid, Eman M ^a   Gumaa, Khalid A ^a   Masuadi, Emad M ^b   Singh, Jaipaul ^c  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Angiotensinconverting enzyme; Bahraini population; Diabetic nephropathy; Insertion deletion polymorphism; Type 2 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; BAHRAIN; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GEL ELECTROPHORESIS; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; BAHRAIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 79953693248     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0688-y     Document Type: Article

References (49)

1. King H, Rewers M (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16:157-177 (Pubitemid 23013841)
2. Wild R, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
3. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO consultation (2006) World Health Org, Geneva
4. Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14:S1-S85
5. Najjar S (2002) Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 13:240-245
6. McLarty DG, Swai AB, Kitange HM, Masuki G, Mtinangi BL, Kilima PM, Makene WJ, Chuwa LM, Alberti KG (1989) Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet 1:871-875 (Pubitemid 19107877)
7. Froguel P, Velho G (2001) Genetic determinants of type 2 diabetes. Recent Prog Horm Res 56:91-105
8. Kussman MJ, Goldstein H, Gleason RE (1976) The clinical course of diabetic nephropathy. JAMA 236:1861-1863
9. White KE, Bilous RW (2000) Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 11:1667-1673
10. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93 (Pubitemid 14084080)
11. Woeste G, Wullstein C, Zapletal C, Hauser IA, Gossmann J, Geiger H, Bechstein WO (2006) Evaluation of type 1 diabetics for simultaneous pancreas-kidney transplantation with regard to cardiovascular risk. Transplant Proc 38:747-750
12. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-266
13. Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133 (Pubitemid 29466226)
14. Yang WC, Hwang SJ, Taiwan Society of Nephrology (2008) Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 23:3977-3982
15. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225-232 (Pubitemid 35463925)
16. Sarnak MJ, Levey AS (2000) Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35:S117-S131 (Pubitemid 30183825)
17. Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK (2005) Polymorphism of the ACE Gene in dialysis patients overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 46:779-787 (Pubitemid 43085180)
18. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion deletion polymorphism in angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346 (Pubitemid 20370444)
19. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205
20. Arzu Ergen H, Hatemi H, Agachan B, Camlica H, Isbir T (2004) Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 36:345-350 (Pubitemid 39279530)
21. Obineche EN, Frossard PM, Bokhari AM (2001) An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 24:635-639 (Pubitemid 33133776)
22. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in Whites. Arterioscler Thromb Vasc Biol 20:484-492 (Pubitemid 30086107)
23. Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K (1999) Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 99:340-343 (Pubitemid 29051257)
24. Ramachandran V, Ismail P, Stanslas J, Shamsudin N, Moin S, Mohd Jas R (2008) Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst 9:208-214
25. Gesang L, Liu G, Cen W, Qiu C, Zhuoma C, Zhuang L, Ren D, Pincuo Z, Chan Y (2002) Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 25:481-485 (Pubitemid 34752570)
26. Ortega-Pierres LE, Gómez García A, Rodríguez-Ayala E, Figueroa-Núñez B, Farias-Rodríguez VM, Higareda-Mendoza AE, Pardo-Galván MA, Cortés-García JC, López-Meza JE, Alvarez-Aguilar C (2007) Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy. Med Clin (Barc) 129:6-10 (Pubitemid 47413825)
27. Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, Mubigonda S, Saharia S, Shastry JC, Hasan Q (2007) Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complicat 21:237-241 (Pubitemid 47002317)
28. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K (2001) Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2:83-87 (Pubitemid 38963875)
29. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T (1998) Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47-53 (Pubitemid 28105740)
30. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F (1997) Contribution of genetic polymorphism in the reninangiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595 (Pubitemid 27163809)
31. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O (1996) Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664 (Pubitemid 26274398)
32. Al-Mahroos F, McKeigue PM (1998) High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936-942
33. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW (2008) Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 31:96-98
34. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433 (an abstract)
35. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711
36. Shanmugan V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3:120-121
37. Kumar PJ, Clark ML (2007) Diabetes mellitus and other endocrine disorders. In: Kumar PJ, Clark ML (eds) Textbook of clinical medicine chapter 19, 7th edn. Saunders, London, pp 1069-1121
38. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ, Humphries SE (2005) The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 84:83-89 (Pubitemid 40082608)
39. Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes HV, Akalin A, Kurt H, Urhan M, Demirustu C (2005) Frequency of angiotensin- converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract 59:1137-1142 (Pubitemid 43904518)
40. Lee YJ, Tsai JC (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25:1002-1008
41. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, Wang G, Xu X (2002) Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 51:1986-1988 (Pubitemid 34564315)
42. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, Tsai JH (2000) Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 15:1008-1013
43. Chuang LM, Chiu KC, Chiang FT, Lee KC, Wu HP, Lin BJ, Tai TY (1997) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin- dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 46:1211-1214 (Pubitemid 27418514)
44. Nitiyanant W, Sriussadaporn S, Ploybutr S, Watanakejorn P, Tunlakit M, Bejrachandra S (1997) Angiotensin converting enzyme gene polymorphism in healthy Thais and patients with non-insulin dependent diabetes mellitus. J Med Assoc Thai 80:747-752
45. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E (1997) Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 12:427-429 (Pubitemid 27105613)
46. Ha SK, Park HC, Park HS, Kang BS, Lee TH, Hwang HJ, Kim SJ, Kim DH, Kang SW, Choi KH, Lee HY, Han DS (2003) ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis 41:943-949 (Pubitemid 36532128)
47. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM (1998) Association between the angiotensin-converting enzyme -insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 9:1653-1663
48. Tarnow L (1996) Genetic pattern in diabetic nephropathy. Nephrol Dial Transplant 11:410-412
49. Fava S, Azzopardi J, Ellard S, Hattersley AT (2001) ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care 24:2115-2120 (Pubitemid 33716531)